Developer docs
API playgroundTry for free, no card

Search company profiles

SelectBio

Full company profile

uuid000o4bt

Namestring
SelectBio
Legal namestring
Select Biosciences
Company typeenum
Private
Founded yearint
1999
Descriptiontext

SelectBio, operating under the legal entity Select Biosciences, is a Vancouver, USA-based private conference and exhibition organizer focused exclusively on the life sciences sector. The company was founded in 1999 and operates with a headcount of 11-50 employees, generating revenue primarily through delegate registration fees and exhibitor/sponsorship packages for its portfolio of scientific conferences. SelectBio does not develop scientific instruments or reagents itself; rather, its product is the convening of researchers, academic scientists, and life science technology companies around narrow scientific topics where generalist conferences would dilute attendee relevance.

The company's product portfolio for 2026 comprises 15+ scheduled conferences spanning microfluidics and lab-on-a-chip, extracellular vesicles (EVs) and exosomes, lipid nanoparticles (LNPs), point-of-care and rapid diagnostics, flow chemistry, and space biotechnology. Events are held across North America (Portland, Denver, Laguna Hills), Europe (Montpellier, France), and Asia-Pacific (Shenzhen, Tokyo-Narita, Kuala Lumpur). SelectBio also offers registration support services and email-based delegate and exhibitor engagement, and introduced a webinars/virtual events channel in 2026 to complement in-person programming. Underlying technology consists of a conference and exhibition management platform supporting delegate registration, event logistics, and direct email outreach; no proprietary AI/ML, data products, or software APIs are offered.

SelectBio's go-to-market is event-driven: the company markets each conference through its corporate website and a delegate email database, leveraging long-standing relationships within specialized scientific communities. Customer segments split between persona-based individual attendees (life science researchers and academics) and business-based sponsors/exhibitors (life science technology companies commercializing instruments, EV analysis tools, LNP delivery systems, and diagnostics). Pricing is not publicly disclosed and is quote-based per conference and delegate type, with registration support managed via a single email channel. The company appears to be independently held with no disclosed institutional investors, parent company, or PE/VC backing, consistent with a cash-generative small business serving a stable, recurring niche.

Short descriptiontext

SelectBio is a privately held Vancouver, USA-based organizer of niche life science conferences and exhibitions, serving academic researchers and life science technology companies across microfluidics, extracellular vesicles, lipid nanoparticles, diagnostics, and related biomedical verticals through 15+ annual global events.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersPalo Alto, United States
HQ citystring
Palo Alto
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
life science conferences, scientific event management, microfluidics conferences, biomedical exhibition services, extracellular vesicles symposiums
Product category
Scientific Conference and Exhibition Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Conference Registration and Exhibition Fees
TypeTransaction Fee
Description

SelectBIO generates revenue through delegate registration fees for conference attendance and exhibition/sponsorship packages for companies showcasing products and services at their life science conferences. The company organizes 15+ conferences annually across multiple global locations.

selectbioconferences.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Operations, Personnel, Marketing or Sales, Technology or R&D
Pricing details1 tier
1Conference delegate registration fees
ModelOtherBilling cadencePay-as-you-go
Notes

Registration fees vary by conference and delegate type; not publicly listed on website

selectbioconferences.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

SelectBio organizes and hosts 15+ scientific conferences and exhibitions annually in highly specialized life science domains including microfluidics, lab-on-a-chip, extracellular vesicles (EVs), lipid nanoparticles (LNPs), point-of-care diagnostics, flow chemistry, and space biotechnology. The company delivers these events across global venues in North America, Europe, and Asia-Pacific, generating revenue through delegate registration fees and corporate exhibition/sponsorship packages.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

SelectBio is a life science conferences company that organizes a portfolio of scientific conferences and exhibitions focused on microfluidics, lab-on-a-chip technologies, extracellular vesicles (EVs), exosomes, lipid nanoparticles (LNPs), point-of-care diagnostics, flow chemistry, and space biotechnology. The company's offering consists of individual conference events organized by topic and geographic region, spanning North America (Portland, Denver, Laguna Hills), Europe (Montpellier), and Asia-Pacific (Shenzhen, Tokyo-Narita, Kuala Lumpur). Each conference serves as a venue for scientific exchange, featuring topics such as EV cargo analysis tools, next-generation instruments, biomarkers, diagnostics, wearable technologies, and 3D-printing applications. The portfolio includes 15 scheduled conferences for 2026, with some events combining related topics (e.g., Microfluidics, EVs & LNPs Europe; EVs & LNPs Laguna Hills).

Product and service15 records
1Microfluidics for Biomedical Innovation 2026
CategoryConference
Description

A two-day conference focused on microfluidics technologies for biomedical applications, held in Shenzhen, China in January 2026. Targeted at scientists, researchers, and life science technology companies working in microfluidics and lab-on-a-chip.

2Extracellular Vesicles 2026: Tools, Biomarkers & Diagnostics
CategoryConference
Description

A two-day conference covering extracellular vesicles tools, biomarkers, and diagnostic applications, held in Shenzhen, China in January 2026. For researchers and technology vendors in EV/exosome science and diagnostics.

3Extracellular Vesicle (EV) Cargo and Functional Analysis Tools 2026
CategoryConference
Description

A conference focused on EV cargo analysis and functional analysis tools, held in Portland, Oregon in March 2026. For researchers and tool providers in extracellular vesicle analytical methods.

4Next-Gen Instruments & Tools Driving EV Research 2026
CategoryConference
Description

Conference showcasing next-generation instruments and tools for extracellular vesicle research, held in Denver, Colorado in March 2026. Targets instrument vendors and EV researchers.

5Flow Chemistry Asia 2026
CategoryConference
Description

A two-day conference on flow chemistry and API synthesis, held in Shenzhen, China in June 2026. For researchers and technology providers in flow chemistry and chemical synthesis.

6Innovations in Microfluidics, Extracellular Vesicles & Lipid Nanoparticles Europe 2026
CategoryConference
Description

Combined conference on microfluidics, EVs, and LNPs innovations, held in Montpellier, France in September 2026. Targets European researchers and technology vendors across the three intersecting verticals.

7Microfluidics, 3D-Printing, Point-of-Care-Rapid Diagnostics Japan 2026
CategoryConference
Description

Conference covering microfluidics, 3D-printing technologies, and rapid diagnostics, held in Tokyo-Narita, Japan in October 2026. For researchers and vendors in diagnostics and 3D bioprinting.

8Lipid Nanoparticles (LNPs) Asia/Pacific 2026
CategoryConference
Description

Conference focused on lipid nanoparticle research and applications in the Asia-Pacific region, held in Tokyo-Narita, Japan in October 2026. Targets researchers and technology providers in LNP delivery systems.

9Extracellular Vesicles (EV) Asia/Pacific-Japan 2026
CategoryConference
Description

Asia/Pacific-focused conference on extracellular vesicles research, held in Tokyo-Narita, Japan in October 2026. For EV researchers and vendors in the region.

10Space Summit Asia-Pacific 2026
CategoryConference
Description

Space Summit conference covering space biotechnology and life sciences applications in the Asia-Pacific region, held in Tokyo-Narita, Japan in October 2026. Targets researchers and companies in space biotech and life sciences.

11Lab-on-a-Chip & Microfluidics World Congress 2026
CategoryConference
Description

World congress on lab-on-a-chip technologies and microfluidics, held in Laguna Hills, California in October 2026. For the global microfluidics research and technology community.

12Extracellular Vesicles (EVs) & Lipid Nanoparticles (LNPs) 2026
CategoryConference
Description

Combined conference on extracellular vesicles and lipid nanoparticles research, held in Laguna Hills, California in October 2026. Targets researchers and vendors across both EVs and LNPs verticals.

13Space Summit West 2026
CategoryConference
Description

Space Summit covering western region space biotechnology topics, held in Laguna Hills, California in October 2026. Targets researchers and companies in space biotech and life sciences.

14Extracellular Vesicles Asia 2026: Tools to Dx and Rx
CategoryConference
Description

Conference focused on extracellular vesicle tools for diagnostics and therapeutics in Asia, held in Kuala Lumpur, Malaysia in December 2026. For EV researchers and diagnostic/therapeutic technology vendors.

15Point-of-Care, Rapid Diagnostics & Biosensors 2026
CategoryConference
Description

Conference on point-of-care diagnostics, rapid testing, and biosensor technologies, held in Kuala Lumpur, Malaysia in December 2026. For diagnostics researchers and rapid test/biosensor technology vendors.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

A direct competitor organizing niche life science conferences across biologics, diagnostics, and drug discovery. Highly comparable in targeting research-driven audiences with multi-topic specialized events.

TypeDirect peer
Description

Specialist life science conference organizer with deep coverage of biopharma R&D, biomarkers, and translational research. Closely comparable niche-led event business model.

TypeDirect peer
Description

Organizes specialized life science and biomedical conferences in areas including biologics, NGS, and drug discovery. Comparable in focusing on narrow R&D verticals with academic/industry audiences.

TypeBroad incumbent
Description

Global events giant with a sizable life science portfolio. Competes in adjacent conference verticals with significantly larger scale, brand, and sponsor relationships.

TypeBroad incumbent
Description

Large incumbent organizer of B2B exhibitions and conferences, including life science adjacent events. Broader portfolio and deeper resources create competitive pressure.

6Elsevier (Events)
TypeBroad incumbent
Description

Scientific publisher that runs life science conferences and uses its journal brand and author networks to attract delegates. Comparable in serving biomedical research communities.

TypeEmerging player
Description

Membership organization running conferences on lab automation, screening, and microfluidics-adjacent topics. Overlaps with SelectBio's lab-on-a-chip and screening audiences.

8CHI Health Bio (Bio-IT World conferences)
TypeEmerging player
Description

Operates conferences serving life science informatics, diagnostics, and translational research communities, partially overlapping SelectBio's diagnostics and tools audiences.

TypeOthers
Description

Life science media brand that runs conferences and events. Comparable audience reach in biotech but operates more as a media/events hybrid than a pure conference promoter.

TypeOthers
Description

Biotech industry information and events business. Serves overlapping executive and investor audiences in life sciences with adjacent conferences and editorial products.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SelectBio

Scientific Conference and Exhibition Servicesselectbiosciences.com

SelectBio is a privately held Vancouver, USA-based organizer of niche life science conferences and exhibitions, serving academic researchers and life science technology companies across microfluidics, extracellular vesicles, lipid nanoparticles, diagnostics, and related biomedical verticals through 15+ annual global events.

What SelectBio does

SelectBio, operating under the legal entity Select Biosciences, is a Vancouver, USA-based private conference and exhibition organizer focused exclusively on the life sciences sector. The company was founded in 1999 and operates with a headcount of 11-50 employees, generating revenue primarily through delegate registration fees and exhibitor/sponsorship packages for its portfolio of scientific conferences. SelectBio does not develop scientific instruments or reagents itself; rather, its product is the convening of researchers, academic scientists, and life science technology companies around narrow scientific topics where generalist conferences would dilute attendee relevance.

The company's product portfolio for 2026 comprises 15+ scheduled conferences spanning microfluidics and lab-on-a-chip, extracellular vesicles (EVs) and exosomes, lipid nanoparticles (LNPs), point-of-care and rapid diagnostics, flow chemistry, and space biotechnology. Events are held across North America (Portland, Denver, Laguna Hills), Europe (Montpellier, France), and Asia-Pacific (Shenzhen, Tokyo-Narita, Kuala Lumpur). SelectBio also offers registration support services and email-based delegate and exhibitor engagement, and introduced a webinars/virtual events channel in 2026 to complement in-person programming. Underlying technology consists of a conference and exhibition management platform supporting delegate registration, event logistics, and direct email outreach; no proprietary AI/ML, data products, or software APIs are offered.

SelectBio's go-to-market is event-driven: the company markets each conference through its corporate website and a delegate email database, leveraging long-standing relationships within specialized scientific communities. Customer segments split between persona-based individual attendees (life science researchers and academics) and business-based sponsors/exhibitors (life science technology companies commercializing instruments, EV analysis tools, LNP delivery systems, and diagnostics). Pricing is not publicly disclosed and is quote-based per conference and delegate type, with registration support managed via a single email channel. The company appears to be independently held with no disclosed institutional investors, parent company, or PE/VC backing, consistent with a cash-generative small business serving a stable, recurring niche.

SelectBio firmographics

Firmographics
Name
SelectBio
Legal name
Select Biosciences
Website
https://selectbiosciences.com
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
11–50 employees
Short description
SelectBio is a privately held Vancouver, USA-based organizer of niche life science conferences and exhibitions, serving academic researchers and life science technology companies across microfluidics, extracellular vesicles, lipid nanoparticles, diagnostics, and related biomedical verticals through 15+ annual global events.
Ownership category
akta.pro rank

Where SelectBio is headquartered

Location

Headquarters

HQ city
Palo Alto
HQ country
United States
HQ region
North America

Markets served

SelectBio business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

  1. Conference Registration and Exhibition Fees: SelectBIO generates revenue through delegate registration fees for conference attendance and exhibition/sponsorship packages for companies showcasing products and services at their life science conferences. The company organizes 15+ conferences annually across multiple global locations.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goConference delegate registration fees

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

SelectBio product offering

Product offering

Core offering

SelectBio organizes and hosts 15+ scientific conferences and exhibitions annually in highly specialized life science domains including microfluidics, lab-on-a-chip, extracellular vesicles (EVs), lipid nanoparticles (LNPs), point-of-care diagnostics, flow chemistry, and space biotechnology. The company delivers these events across global venues in North America, Europe, and Asia-Pacific, generating revenue through delegate registration fees and corporate exhibition/sponsorship packages.

Product overview

SelectBio is a life science conferences company that organizes a portfolio of scientific conferences and exhibitions focused on microfluidics, lab-on-a-chip technologies, extracellular vesicles (EVs), exosomes, lipid nanoparticles (LNPs), point-of-care diagnostics, flow chemistry, and space biotechnology. The company's offering consists of individual conference events organized by topic and geographic region, spanning North America (Portland, Denver, Laguna Hills), Europe (Montpellier), and Asia-Pacific (Shenzhen, Tokyo-Narita, Kuala Lumpur). Each conference serves as a venue for scientific exchange, featuring topics such as EV cargo analysis tools, next-generation instruments, biomarkers, diagnostics, wearable technologies, and 3D-printing applications. The portfolio includes 15 scheduled conferences for 2026, with some events combining related topics (e.g., Microfluidics, EVs & LNPs Europe; EVs & LNPs Laguna Hills).

Differentiator

Problem solved

Functional benefit

Products and services

  • Microfluidics for Biomedical Innovation 2026 A two-day conference focused on microfluidics technologies for biomedical applications, held in Shenzhen, China in January 2026. Targeted at scientists, researchers, and life science technology companies working in microfluidics and lab-on-a-chip.
  • Extracellular Vesicles 2026: Tools, Biomarkers & Diagnostics A two-day conference covering extracellular vesicles tools, biomarkers, and diagnostic applications, held in Shenzhen, China in January 2026. For researchers and technology vendors in EV/exosome science and diagnostics.
  • Extracellular Vesicle (EV) Cargo and Functional Analysis Tools 2026 A conference focused on EV cargo analysis and functional analysis tools, held in Portland, Oregon in March 2026. For researchers and tool providers in extracellular vesicle analytical methods.
  • Next-Gen Instruments & Tools Driving EV Research 2026 Conference showcasing next-generation instruments and tools for extracellular vesicle research, held in Denver, Colorado in March 2026. Targets instrument vendors and EV researchers.
  • Flow Chemistry Asia 2026 A two-day conference on flow chemistry and API synthesis, held in Shenzhen, China in June 2026. For researchers and technology providers in flow chemistry and chemical synthesis.
  • Innovations in Microfluidics, Extracellular Vesicles & Lipid Nanoparticles Europe 2026 Combined conference on microfluidics, EVs, and LNPs innovations, held in Montpellier, France in September 2026. Targets European researchers and technology vendors across the three intersecting verticals.
  • Microfluidics, 3D-Printing, Point-of-Care-Rapid Diagnostics Japan 2026 Conference covering microfluidics, 3D-printing technologies, and rapid diagnostics, held in Tokyo-Narita, Japan in October 2026. For researchers and vendors in diagnostics and 3D bioprinting.
  • Lipid Nanoparticles (LNPs) Asia/Pacific 2026 Conference focused on lipid nanoparticle research and applications in the Asia-Pacific region, held in Tokyo-Narita, Japan in October 2026. Targets researchers and technology providers in LNP delivery systems.
  • Extracellular Vesicles (EV) Asia/Pacific-Japan 2026 Asia/Pacific-focused conference on extracellular vesicles research, held in Tokyo-Narita, Japan in October 2026. For EV researchers and vendors in the region.
  • Space Summit Asia-Pacific 2026 Space Summit conference covering space biotechnology and life sciences applications in the Asia-Pacific region, held in Tokyo-Narita, Japan in October 2026. Targets researchers and companies in space biotech and life sciences.
  • Lab-on-a-Chip & Microfluidics World Congress 2026 World congress on lab-on-a-chip technologies and microfluidics, held in Laguna Hills, California in October 2026. For the global microfluidics research and technology community.
  • Extracellular Vesicles (EVs) & Lipid Nanoparticles (LNPs) 2026 Combined conference on extracellular vesicles and lipid nanoparticles research, held in Laguna Hills, California in October 2026. Targets researchers and vendors across both EVs and LNPs verticals.
  • Space Summit West 2026 Space Summit covering western region space biotechnology topics, held in Laguna Hills, California in October 2026. Targets researchers and companies in space biotech and life sciences.
  • Extracellular Vesicles Asia 2026: Tools to Dx and Rx Conference focused on extracellular vesicle tools for diagnostics and therapeutics in Asia, held in Kuala Lumpur, Malaysia in December 2026. For EV researchers and diagnostic/therapeutic technology vendors.
  • Point-of-Care, Rapid Diagnostics & Biosensors 2026 Conference on point-of-care diagnostics, rapid testing, and biosensor technologies, held in Kuala Lumpur, Malaysia in December 2026. For diagnostics researchers and rapid test/biosensor technology vendors.

Companies that use SelectBio

Customer profile

Segments2 records

Ideal customer profiles2 records

SelectBio technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

SelectBio partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves4 records

Expansion highlights4 records

SelectBio competitors and assessment

Company assessment

Direct peers

  • Cambridge Healthtech Institute (CHI): A direct competitor organizing niche life science conferences across biologics, diagnostics, and drug discovery. Highly comparable in targeting research-driven audiences with multi-topic specialized events.
  • Hanson Wade: Specialist life science conference organizer with deep coverage of biopharma R&D, biomarkers, and translational research. Closely comparable niche-led event business model.
  • Oxford Global: Organizes specialized life science and biomedical conferences in areas including biologics, NGS, and drug discovery. Comparable in focusing on narrow R&D verticals with academic/industry audiences.

Broad incumbents

  • Informa (Life Sciences division): Global events giant with a sizable life science portfolio. Competes in adjacent conference verticals with significantly larger scale, brand, and sponsor relationships.
  • Reed Exhibitions: Large incumbent organizer of B2B exhibitions and conferences, including life science adjacent events. Broader portfolio and deeper resources create competitive pressure.
  • Elsevier (Events): Scientific publisher that runs life science conferences and uses its journal brand and author networks to attract delegates. Comparable in serving biomedical research communities.

Emerging players

  • SLAS (Society for Laboratory Automation and Screening): Membership organization running conferences on lab automation, screening, and microfluidics-adjacent topics. Overlaps with SelectBio's lab-on-a-chip and screening audiences.
  • CHI Health Bio (Bio-IT World conferences): Operates conferences serving life science informatics, diagnostics, and translational research communities, partially overlapping SelectBio's diagnostics and tools audiences.

Others

  • Fierce Biotech / Fierce Pharma (Events): Life science media brand that runs conferences and events. Comparable audience reach in biotech but operates more as a media/events hybrid than a pure conference promoter.
  • BioCentury: Biotech industry information and events business. Serves overlapping executive and investor audiences in life sciences with adjacent conferences and editorial products.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

SelectBio social profiles

Digital presence

SelectBio financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SelectBio leadership team

Management profile

Number of profiles

SelectBio funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SelectBio M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SelectBio

What does SelectBio do?

SelectBio organizes and hosts 15+ scientific conferences and exhibitions annually in highly specialized life science domains including microfluidics, lab-on-a-chip, extracellular vesicles (EVs), lipid nanoparticles (LNPs), point-of-care diagnostics, flow chemistry, and space biotechnology. The company delivers these events across global venues in North America, Europe, and Asia-Pacific, generating revenue through delegate registration fees and corporate exhibition/sponsorship packages.

Is SelectBio a public or private company?

SelectBio is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was SelectBio founded?

SelectBio was founded in 1999. It employs 11 to 50 people.

Where is SelectBio based?

SelectBio is headquartered in Palo Alto, United States, in the North America region.

How does SelectBio make money?

One revenue line is on record: conference Registration and Exhibition Fees.

Who are SelectBio's main competitors?

Direct peers on record are Cambridge Healthtech Institute (CHI), Hanson Wade and Oxford Global. Broad incumbents are Informa (Life Sciences division), Reed Exhibitions and Elsevier (Events). Emerging players are SLAS (Society for Laboratory Automation and Screening) and CHI Health Bio (Bio-IT World conferences). Others are Fierce Biotech / Fierce Pharma (Events) and BioCentury.

Does SelectBio have an API?

No public API is recorded for SelectBio.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales